This research paper
describes the fabrication of bionanocomposites
(BNCs) based on silk fibroin (SF) and reduced graphene oxide (rGO).
The recorded UV–visible (UV–vis) spectra of the sample
confirm the reduction of GO to rGO in SF by showing a plasmon resonance
band within the wavelength range of 261–268 nm. The X-ray diffraction
(XRD) peak at 11.6° corresponding to the GO intensity decreases
with increasing reaction time, resulting in rGO in the SF host matrix.
The morphological behavior of the SF–rGO BNCs is scrutinized
using scanning electron microscopy (SEM), and the images clearly indicate
the existence of rGO within the matrix. The increasing amount of GO
in the SF shows broken graphene sheets, which can increase the surface
roughness and establish a strong physical contact between the SF and
rGO nanosheets. The high-resolution transmission electron microscope
(HR-TEM) image of the bionanocomposite showed that the formed rGO
encompassments of fewer layers are stacked, each with fewer wrinkles
and folding. The Raman spectroscopy confirmed the formation of rGO
by showing the increased intensity ratio of D to G band (I
D/I
G) in the bionanocomposite
samples. The rGO effect on the electrical conductivity is measured,
and the results show that DC conductivity increases from 1.28 ×
10–9 to 82.4 × 10–9 S/cm
with an increase in the GO content in the SF biopolymer. The investigations
demonstrate loss of the insulation property and improved conducting
behavior of the SF biopolymer.
In the current study, an attempt was made to fabricate the silk fibroin/graphene oxide (SF/GO) blend films. Obtained blend films were characterised by UV-visible spectroscopy (UV-Vis) confirmed the GO blending...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.